TIFA Antikörper (AA 1-184)

Produktnummer ABIN7172332

Produktdetails anti-TIFA Antikörper

Target: TIFA (TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA))

Bindungsspezifität: AA 1-184

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TIFA Antikörper ist unkonjugiert

Applikation: ELISA

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human TRAF-interacting protein with FHA domain-containing protein A protein (1-184AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu TIFA

Target: TIFA (TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA))

Andere Bezeichnung: TIFA (TIFA Produkte)

Synonyme: TIFA antikoerper, xtifa antikoerper, T2BP antikoerper, T6BP antikoerper, TIFAA antikoerper, T2bp antikoerper, Ab2-389 antikoerper, TRAF interacting protein with forkhead associated domain antikoerper, TRAF-interacting protein with forkhead-associated domain antikoerper, TRAF-interacting protein with forkhead-associated domain S homeolog antikoerper, TIFA antikoerper, tifa antikoerper, Tifa antikoerper, tifa.S antikoerper

Hintergrund:

Background: Adapter protein which mediates the IRAK1 and TRAF6 interaction following IL-1 stimulation, resulting in the downstream activation of NF-kappa-B and AP-1 pathways. Induces the oligomerization and polyubiquitination of TRAF6, which leads to the activation of TAK1 and IKK through a proteasome-independent mechanism.

Aliases: Putative MAPK activating protein PM14 antibody, Putative MAPK-activating protein PM14 antibody, Putative NF kappa B activating protein 20 antibody, Putative NF-kappa-B-activating protein 20 antibody, T2BP antibody, TIFA antibody, TIFA_HUMAN antibody, TRAF interacting protein with FHA domain containing protein A antibody, TRAF-interacting protein with FHA domain-containing protein A antibody, TRAF2 binding protein antibody, TRAF2-binding protein antibody

UniProt: Q96CG3